The President of the Agency for Health Technology Assessment and Tariff System informs medical entities which have concluded a contract on the provision of specialist outpatient care about the possibility of making the data available to the Agency necessary to set tariffs for selected guaranteed health care services: bone marrow aspiration biopsy and bone marrow trepanobiopsy.